TY  - JOUR
AU  - Soria-Juan, Bárbara
AU  - Escacena, Natalia
AU  - Capilla-González, Vivian
AU  - Aguilera, Yolanda
AU  - Llanos, Lucía
AU  - Tejedo, Juan R
AU  - Bedoya, Francisco J
AU  - Juan, Verónica
AU  - De la Cuesta, Antonio
AU  - Ruiz-Salmerón, Rafael
AU  - Andreu, Enrique
AU  - Grochowicz, Lukas
AU  - Prósper, Felipe
AU  - Sánchez-Guijo, Fermín
AU  - Lozano, Francisco S
AU  - Miralles, Manuel
AU  - Del Río-Solá, Lourdes
AU  - Castellanos, Gregorio
AU  - Moraleda, José M
AU  - Sackstein, Robert
AU  - García-Arranz, Mariano
AU  - García-Olmo, Damián
AU  - Martín, Franz
AU  - Hmadcha, Abdelkrim
AU  - Soria, Bernat
AU  - Collaborative Working Group “Noma Project Team”
PY  - 2019
DO  - 10.3389/fimmu.2019.01151
UR  - http://hdl.handle.net/10668/14162
T2  - Frontiers in immunology
AB  - Cell therapy is a progressively growing field that is rapidly moving from preclinical model development to clinical application. Outcomes obtained from clinical trials reveal the therapeutic potential of stem cell-based therapy to deal with unmet...
LA  - en
KW  - cell-based therapy
KW  - cellular medicaments
KW  - clinical trials
KW  - cost-effective
KW  - critical limb ischemia
KW  - diabetes
TI  - Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.
TY  - research article
VL  - 10
ER  -